Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Irina Liberman"'
Publikováno v:
VIII МЕЖДУНАРОДНАЯ КОНФЕРЕНЦИЯ ПРОБЛЕМЫ МЕХАНИКИ СОВРЕМЕННЫХ МАШИН. Сборник статей конференции.
Publikováno v:
Frontier Information Technology and Systems Research in Cooperative Economics ISBN: 9783030578305
A universal system-target method for modeling and reengineering of business processes in cooperative enterprises is proposed, which allows us to overcome the inertia and systematicity in the management of cooperative enterprises and eliminate the sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3aa3a47a7cded382a6960e572c2a120
https://doi.org/10.1007/978-3-030-57831-2_75
https://doi.org/10.1007/978-3-030-57831-2_75
Publikováno v:
Transportation Research Procedia. 36:326-333
The authors of this article are presenting the concepts of intelligent vehicle control systems development on the basis of author’s concept of "soft" mathematical modeling of complex systems by method of heuristic correction of basic analytical dep
Autor:
Selwyn J. Hurwitz, Yuliya Glazkova, Raymond F. Schinazi, Nicolas Mourier, Irina Liberman, Thomas E. Keane, Jeffrey J. Olson
Publikováno v:
ChemInform. 35
The carboranyl nucleotides β‐d‐5‐o‐carboranyl‐2′‐deoxyuridine (d‐CDU), 1‐(β‐l‐arabinosyl)‐5‐o‐carboranyluracil (d‐ribo‐CU) and the nucleotide base 5‐o‐carboranyluracil (CU), were developed as sensitizers for boro
Autor:
Thomas E. Keane, Irina Liberman, Yuliya Glazkova, Selwyn J. Hurwitz, Raymond F. Schinazi, Nicolas Mourier, Jeffrey J. Olson
Publikováno v:
Nucleosides, nucleotidesnucleic acids. 23(1-2)
The carboranyl nucleotides beta-D-5-o-carboranyl-2'-deoxyuridine (D-CDU), 1-(beta-L-arabinosyl)-5-o-carboranyluracil (D-ribo-CU) and the nucleotide base 5-o-carboranyluracil (CU), were developed as sensitizers for boron neutron capture therapy (BNCT)
Autor:
Bud C. Tennant, John L. Gerin, Selwyn J. Hurwitz, Raymond F. Schinazi, Irina Liberman, Brent E. Korba
Publikováno v:
Antiviral chemistrychemotherapy. 13(3)
There is a need for adequate models of virus depletion in animals and humans as a function of drug dose in order to plan starting dose regimens in the clinic for new antiretroviral nucleoside agents. An indirect response pharmacodynamic model was fit
Autor:
Karen S. Anderson, Irina Liberman, Edgar Hill, William C. Copeland, Joy Y. Feng, George R. Painter, Jean-Pierre Sommadossi, Raymond F. Schinazi, Katyna Borroto-Esoda, Chung K. Chu, Phillip A. Furman, Laura L. Kiefer, Jerry L. Jeffrey
Human immunodeficiency virus (HIV) type 1 (HIV-1) encodes an Mg2+-dependent reverse transcriptase (RT) which is required for virus replication and which is a proven target for the chemotherapy of HIV infection. Currently, strategies for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee41e3fccc1c8b5af5cd47507f26224
https://europepmc.org/articles/PMC90254/
https://europepmc.org/articles/PMC90254/
Autor:
Jeffrey A. Coderre, Selwyn J. Hurwitz, Dennis C. Liotta, Amy Juodawlkis, Junxing Shi, Jeffrey Olson, Raymond F. Schinazi, Irina Liberman
Publikováno v:
Frontiers in Neutron Capture Therapy ISBN: 9781461354789
The major concerns in drug development for boron neutron capture therapy (BNCT) include the accumulation of sufficient boron in tumor tissue, while limiting exposure in neighboring non-tumor tissue. Since BNCT is a binary treatment where cellular tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43a6d3e2e99a10b5864c456a48baff70
https://doi.org/10.1007/978-1-4615-1285-1_171
https://doi.org/10.1007/978-1-4615-1285-1_171